title: Effect of neuropeptide Y on bradykinin-induced release of prostacyclin and thromboxane from guinea pig perfused lung.
abstract: We have previously reported that neuropeptide Y (NPY) inhibits responses induced by various agonists (noradrenaline, vasoactive intestinal peptide, substance P,5-hydroxytryptamine) in isolated guinea pig trachea. Although the underlying mechanisms have not been fully characterized, it was found that the NPY-evoked inhibition was specifically expressed with agents for which locally released prostaglandins (PGs) are important determinants for their myotropic activity. In the present study, we have extended these findings by examining whether NPY was capable of regulating the release of prostacyclin and thromboxane A2 induced by bradykinin (BK) from naive and ovalbumin-sensitized guinea pig perfused lungs. Our results showed that infusion of NPY (0.24 microM) through the lung significantly inhibited the release of 6-keto-PGF1 alpha (> 30%) and thromboxane B2 (50%) induced by intraarterial administration of BK (3 micrograms) from untreated and ovalbumin-sensitized guinea pig perfused lung. However, the inhibitory effect of NPY was lost in the immunological production of prostaglandins. These results suggest that NPY may act as a regulatory agent of the release of cyclooxygenase-derived products by possibly acting on events preceding phospholipase A2 activation.
authors.affiliation: Department of Pharmacology, Faculty of Medicine, Université de Sherbrooke, QC, Canada.
authors.forename: K
authors.initials: K
authors.lastname: Lewis
authors.forename: P
authors.initials: P
authors.lastname: D'Orléans-Juste
authors.forename: M T
authors.initials: MT
authors.lastname: Benchekroun
authors.forename: A
authors.initials: A
authors.lastname: Fournier
authors.forename: A
authors.initials: A
authors.lastname: Cadieux
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000378:metabolism*; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology*; D005260:Female; D006168:Guinea Pigs; D008168:Lung / Q000187:drug effects* / Q000378:metabolism*; D008297:Male; D009478:Neuropeptide Y / Q000494:pharmacology*; D010047:Ovalbumin / Q000378:metabolism / Q000494:pharmacology; D010477:Perfusion; D012680:Sensitivity and Specificity; D013929:Thromboxane B2 / Q000378:metabolism*
chemical_list: D009478:Neuropeptide Y; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; D010047:Ovalbumin; D001920:Bradykinin